Indication

Transitional cell carcinoma of the urinary tract

Transitional cell carcinoma of the urinary tract, also referred to as urothelial carcinoma, is a malignancy arising from the specialized transitional epithelial lining of the urinary system. Read more about Transitional cell carcinoma of the urinary tract

7 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Transitional cell carcinoma of the urinary tract therapies.

Showing 1–7 of 7 drugs

OPDIVO (nivolumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY·MALIGNANT ESOPHAGEAL NEOPLASM·+17
BMS PRIMARYCARE

KEYTRUDA (pembrolizumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY·MALIGNANT MELANOMA·+36
Merck Sharp & Dohme

BAVENCIO (avelumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY·RENAL CELL CARCINOMA·+2
EMD SERONO, INC
Filter & compare in the drug finder →Opens the drug finder with Transitional cell carcinoma of the urinary tract preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Transitional cell carcinoma of the urinary tract.

Transitional cell carcinoma of the urinary tract, also referred to as urothelial carcinoma, is a malignancy arising from the specialized transitional epithelial lining of the urinary system.

It most commonly develops in the urinary bladder, but can originate anywhere along the urinary tract, including the renal pelvis, ureters, and urethra, predominantly affecting older adults.

Pathophysiologically, the tumor often exhibits a field cancerization effect characterized by multifocality and a high tendency for recurrence throughout the urothelium.

Clinically, it typically presents with painless gross or microscopic hematuria, dysuria, or urinary frequency, and lesions can range from noninvasive, low-grade papillary neoplasms to high-grade, muscle-invasive carcinomas prone to systemic metastasis.

Personalize your experience

Follow Transitional cell carcinoma of the urinary tract and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it